Table 5.
Insulin type | Onset of action | Peak effect | Duration of action |
Lispro, aspart, glulisine | 5 to 15 min | 45 to 75 min | 2 to 4 h |
Regular | About 30 min | 2 to 4 h | 5 to 8 h |
NPH | About 2 h | 4 to 12 h | 18 to 28 h |
Insulin glargine | About 2 h | No peak | 20 to 24 h |
Insulin detemir | About 2 h | No peak | 6 to 24 h1 |
NPL | About 2 h | Six hours | 15 h |
Insulin degludec | About 2 h | No peak | > 40 h |
Insulin U-300 | About 2 h | No peak | > 36 h |
Duration of action is dose-dependent. At higher doses (≥ 0.8 units/kg), mean duration of action is longer and less variable. Modified from: McCulloch DK. General principles of insulin therapy in diabetes mellitus. Uptodate, March 24, 2016. Available from: URL: http://www.uptodate.com/contents/general-principles-of-insulin-therapy-in-diabetes-mellitus.